Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1992 Aug;45(8):660–663. doi: 10.1136/jcp.45.8.660

Expression of Ki-67 nuclear antigen in B and T cell lymphoproliferative disorders.

N de Melo 1, E Matutes 1, I Cordone 1, R Morilla 1, D Catovksy 1
PMCID: PMC495139  PMID: 1401173

Abstract

AIMS: To determine whether the proliferation rates of tumour cells may relate to prognosis and reflect disease activity. METHODS: Blood mononuclear cells from 155 patients with B cell (n = 120) or T cell (n = 35) chronic lymphoproliferative disorders were tested with the monoclonal antibody Ki-67 by indirect immunoperoxidase or immunoalkaline phosphatase techniques. B cell diseases included chronic lymphocytic leukaemia (CLL), CLL in prolymphocytic transformation (CLL/PL), prolymphocytic leukaemia (B-PLL) and non-Hodgkin's lymphoma (B-NHL) in leukaemic phase. The T cell diseases comprised large granular lymphocyte (LGL) leukaemia, T-PLL, and T-NHL. RESULTS: These showed significantly higher proportions of Ki-67 positive cells in T cell (11.2%) than in B cell (2.9%) disorders (p < 0.001). The highest values were found in NHL of both B and T cell types, particularly when low grade disease transformed to high grade. The lowest percentages of Ki-67 positive cells were found in CLL (1.4%) and LGL leukaemia (1.7%); intermediate values were seen in B PLL (3.3%) and T PLL (5.8%). CONCLUSIONS: There is a positive correlation between prognosis and proliferation rates in chronic B and T cell lymphoproliferative disorders. Estimation of Ki-67 in circulating leukaemic cells could be used to determine prognosis in low grade malignancies.

Full text

PDF
660

Images in this article

661Image
on p.661
662Image
on p.662

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akerman M., Brandt L., Johnson A., Olsson H. Mitotic activity in non-Hodgkin's lymphoma. Relation to the Kiel classification and to prognosis. Br J Cancer. 1987 Feb;55(2):219–223. doi: 10.1038/bjc.1987.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Binet J. L., Auquier A., Dighiero G., Chastang C., Piguet H., Goasguen J., Vaugier G., Potron G., Colona P., Oberling F. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer. 1981 Jul 1;48(1):198–206. doi: 10.1002/1097-0142(19810701)48:1<198::aid-cncr2820480131>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  3. Catovsky D., Fooks J., Richards S. Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. A report from the MRC CLL 1 trial. MRC Working Party on Leukaemia in Adults. Br J Haematol. 1989 Jun;72(2):141–149. doi: 10.1111/j.1365-2141.1989.tb07674.x. [DOI] [PubMed] [Google Scholar]
  4. Catovsky D. Prolymphocytic leukaemia. Nouv Rev Fr Hematol. 1982;24(6):343–347. [PubMed] [Google Scholar]
  5. Cooper E. H., Peckham M. J., Millard R. E., Hamlin I. M., Gérard-Marchant R. Cell proliferation in human malignant lymphomas. Analysis of labelling index and DNA content in cell populations obtained by biopsy. Eur J Cancer. 1968 Jul;4(3):287–296. doi: 10.1016/0014-2964(68)90054-6. [DOI] [PubMed] [Google Scholar]
  6. Costa A., Bonadonna G., Villa E., Valagussa P., Silvestrini R. Labeling index as a prognostic marker in non-Hodgkin's lymphomas. J Natl Cancer Inst. 1981 Jan;66(1):1–5. [PubMed] [Google Scholar]
  7. Drach J., Gattringer C., Glassl H., Schwarting R., Stein H., Huber H. Simultaneous flow cytometric analysis of surface markers and nuclear Ki-67 antigen in leukemia and lymphoma. Cytometry. 1989 Nov;10(6):743–749. doi: 10.1002/cyto.990100612. [DOI] [PubMed] [Google Scholar]
  8. Falini B., Canino S., Sacchi S., Ciani C., Martelli M. F., Gerdes J., Stein H., Pileri S., Gobbi M., Fagioli M. Immunocytochemical evaluation of the percentage of proliferating cells in pathological bone marrow and peripheral blood samples with the Ki-67 and anti-bromo-deoxyuridine monoclonal antibodies. Br J Haematol. 1988 Jul;69(3):311–320. doi: 10.1111/j.1365-2141.1988.tb02368.x. [DOI] [PubMed] [Google Scholar]
  9. Gerdes J., Dallenbach F., Lennert K., Lemke H., Stein H. Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Hematol Oncol. 1984 Oct-Dec;2(4):365–371. doi: 10.1002/hon.2900020406. [DOI] [PubMed] [Google Scholar]
  10. Gerdes J., Lemke H., Baisch H., Wacker H. H., Schwab U., Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984 Oct;133(4):1710–1715. [PubMed] [Google Scholar]
  11. Gerdes J., Schwab U., Lemke H., Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer. 1983 Jan 15;31(1):13–20. doi: 10.1002/ijc.2910310104. [DOI] [PubMed] [Google Scholar]
  12. Grogan T. M., Lippman S. M., Spier C. M., Slymen D. J., Rybski J. A., Rangel C. S., Richter L. C., Miller T. P. Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67. Blood. 1988 Apr;71(4):1157–1160. [PubMed] [Google Scholar]
  13. Habeshaw J. A., Lister T. A., Stansfeld A. G., Greaves M. F. Correlation of transferrin receptor expression with histological class and outcome in non-Hodgkin lymphoma. Lancet. 1983 Mar 5;1(8323):498–501. doi: 10.1016/s0140-6736(83)92191-8. [DOI] [PubMed] [Google Scholar]
  14. Hall P. A., Richards M. A., Gregory W. M., d'Ardenne A. J., Lister T. A., Stansfeld A. G. The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma. J Pathol. 1988 Mar;154(3):223–235. doi: 10.1002/path.1711540305. [DOI] [PubMed] [Google Scholar]
  15. Kvaløy S., Godal T., Marton P. F., Steen H., Brenhovd I. O., Abrahamsen A. F. Spontaneous (H)-thymidine uptake in histological subgroups of human B-cell lymphomas. Scand J Haematol. 1981 Mar;26(3):221–234. doi: 10.1111/j.1600-0609.1981.tb01650.x. [DOI] [PubMed] [Google Scholar]
  16. Kvaløy S., Marton P. F., Kaalhus O., Høie J., Foss-Abrahamsen A., Godal T. 3H-thymidine uptake in B cell lymphomas--relationship to treatment response and survival. Scand J Haematol. 1985 May;34(5):429–435. doi: 10.1111/j.1600-0609.1985.tb00773.x. [DOI] [PubMed] [Google Scholar]
  17. Look A. T., Melvin S. L., Williams D. L., Brodeur G. M., Dahl G. V., Kalwinsky D. K., Murphy S. B., Mauer A. M. Aneuploidy and percentage of S-phase cells determined by flow cytometry correlate with cell phenotype in childhood acute leukemia. Blood. 1982 Oct;60(4):959–967. [PubMed] [Google Scholar]
  18. Matutes E., Brito-Babapulle V., Swansbury J., Ellis J., Morilla R., Dearden C., Sempere A., Catovsky D. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood. 1991 Dec 15;78(12):3269–3274. [PubMed] [Google Scholar]
  19. Melo J. V., Catovsky D., Galton D. A. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. I. Clinical and laboratory features of 300 patients and characterization of an intermediate group. Br J Haematol. 1986 Jun;63(2):377–387. [PubMed] [Google Scholar]
  20. Melo J. V., Catovsky D., Gregory W. M., Galton D. A. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. IV. Analysis of survival and prognostic features. Br J Haematol. 1987 Jan;65(1):23–29. doi: 10.1111/j.1365-2141.1987.tb06130.x. [DOI] [PubMed] [Google Scholar]
  21. Scott C. S., Ramsden W., Limbert H. J., Master P. S., Roberts B. E. Membrane transferrin receptor (TfR) and nuclear proliferation-associated Ki-67 expression in hemopoietic malignancies. Leukemia. 1988 Jul;2(7):438–442. [PubMed] [Google Scholar]
  22. Shirono K., Hattori T., Takatsuki K. Prognostic usefulness of Ki-67 antigen expression in adult T-cell leukaemia. Lancet. 1989 Oct 28;2(8670):1044–1044. doi: 10.1016/s0140-6736(89)91059-3. [DOI] [PubMed] [Google Scholar]
  23. Suarez C., Miller D. R., Steinherz P. G., Melamed M. M., Andreeff M. DNA and RNA determination in 111 cases of childhood acute lymphoblastic leukaemia (ALL) by flow cytometry: correlation of FAB classification with DNA stemline and proliferation. Br J Haematol. 1985 Aug;60(4):677–686. doi: 10.1111/j.1365-2141.1985.tb07472.x. [DOI] [PubMed] [Google Scholar]
  24. Themi H., Trepel F., Schick P., Kaboth W., Begemann H. Kinetics of lymphocytes in chronic lymphocytic leukemia: studies using continuous 3H-thymidine infusion in two patients. Blood. 1973 Oct;42(4):623–636. [PubMed] [Google Scholar]
  25. Yamada Y., Murata K., Kamihira S., Atogami S., Tsukasaki K., Sohda H., Yanagisako T., Momita S., Jubashi T., Amagasaki T. Prognostic significance of the proportion of Ki-67-positive cells in adult T-cell leukemia. Cancer. 1991 May 15;67(10):2605–2609. doi: 10.1002/1097-0142(19910515)67:10<2605::aid-cncr2820671034>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES